What is Adaptive Biotechnologies Corporation’s 1-month forecast?

Meyka AI projects ADPT could trade near $20.01 in the next month, a move of -5.57% compared to today’s price.

What is Adaptive Biotechnologies Corporation’s 1-year forecast?

By 2027, ADPT is forecasted to reach $24.03, reflecting a 13.40% change from the current level.

What is Adaptive Biotechnologies Corporation’s 5-year forecast?

The 2030 projection for ADPT is $56.49, which represents a potential 166.59% change.

What is the 7-year outlook for Adaptive Biotechnologies Corporation?

Over the next 7 years, ADPT could trade around $75.76, showing a 257.53% move from today’s price.

Can Adaptive Biotechnologies Corporation (ADPT) reach $75 by 2030?

Meyka AI’s 2030 forecast places ADPT at $56.49, making it unlikely to reach $75 by 2030 under current market conditions.

Adaptive Biotechnologies Corporation (ADPT) Stock Forecast 2027, 2031 & 7-Year Price Prediction

Get the latest Adaptive Biotechnologies Corporation (ADPT) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.

ADPT●NASDAQ

HealthcareBiotechnology

$21.19

$1.18(5.27%)

U.S. Market opens in 59h 32m

Adaptive Biotechnologies Corporation (ADPT)

Model Information

The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Monthly Forecast

Predicted Price$20.01

Change↓ $-1.18 (-5.57%)

Quarterly Forecast

Predicted Price$19.43

Change↓ $-1.76 (-8.31%)

Yearly Forecast

Predicted Price$24.03

Change↑ $2.84 (13.40%)

3 Years Forecast

Predicted Price$40.25

Change↑ $19.06 (89.97%)

5 Years Forecast

Predicted Price$56.49

Change↑ $35.30 (166.59%)

7 Years Forecast

Predicted Price$75.76

Change↑ $54.57 (257.53%)

Adaptive Biotechnologies Corporation Stock Forecast Summary

Adaptive Biotechnologies Corporation (ADPT) stock is currently priced at $21.19. Based on Meyka AI predictions, the short-term outlook is bearish, with momentum pointing higher. The 1-month projection suggests a move toward $20.01.

In the long term, ADPT shows a bullish trend. The 2027 forecast points to $24.03 (13.40% change), while the 2031 forecast suggests $56.49 (166.59% change). Looking 7 years ahead, projections estimate the stock could trade near $75.76, a 257.53% change from today’s price.

Overall Sentiment

Neutral

Short-Term Outlook

Bearish

Long-Term Outlook

Bullish

This mix indicates that Adaptive Biotechnologies Corporation stock is expected to rise steadily over the coming years.

Investment Calculator

Estimate your potential returns on ADPT using our advanced Investment Calculator with AI-driven price forecasts. Enter your investment amount and select a target date to view expected results, including estimated profit, loss, and ROI performance.

Based on your investment of $1,000.00 in Adaptive Biotechnologies Corporation and holding until July 4th, 2027, you could face a potential +$133.96 profit, reflecting a +13.4% ROI over the next 365 days. These projections help you better understand short-term market movements.

Investment Amount (USD)

HODL Until?

$Shares Bought

47.1921

@ $21.19/share

~Forecast Price

$24.03

1-year AI forecast

$Est. Portfolio Value

$1,133.96

+$133.96 profit

%ROI

+13.4%

return on investment

Adaptive Biotechnologies Corporation yearly Price Forecast Chart

Explore the yearly forecast chart for ADPT, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Adaptive Biotechnologies Corporation over different timeframes.

No forecast data available

No prediction data found for this time period.

Forecasting data is not available for ADPTForecasting details for ADPT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Adaptive Biotechnologies Corporation Stock Forecast 2026

The forecast for Adaptive Biotechnologies Corporation (ADPT) in 2026 suggests a price of $24.03, representing a 13.40% move from today’s price.

Average Target: $24.03

Market Outlook: bullish based on current trend indicators.

Key Drivers in 2026:

Earnings growth projections.
Competitive performance in the Healthcare.
Macroeconomic factors such as interest rates and inflation.

Adaptive Biotechnologies Corporation Stock Forecast 2030

By 2030, Meyka AI projects ADPT could trade near $56.49, showing a potential 166.59% compared to current levels.

Average Target: $56.49

Market Outlook: bullish.

What could influence the 2030 forecast:

Technological innovation and product cycles.
Expansion into global markets.
Long-term investor sentiment toward Adaptive Biotechnologies Corporation.

Adaptive Biotechnologies Corporation 7-Year Stock Forecast (2032–2033)

Looking 7 years ahead, the long-term forecast for ADPT points to a price around $75.76, which is a projected 257.53% move from today’s level.

Average Target: $75.76

Outlook: bullish, depending on macroeconomic conditions and sector growth.

Long-Term Drivers:

Global economic expansion or contraction.
Regulatory and policy environment.
Adaptive Biotechnologies Corporation’s ability to maintain market leadership.